Can This Silicon Valley Startup Bioengineer A Less Addictive Opioid? – Fast Company
Fast Company |
Can This Silicon Valley Startup Bioengineer A Less Addictive Opioid?
Fast Company She was becoming more and more interested in the interdisciplinary field of synthetic biology, which combines biology, chemistry, engineering, genomics, and computer science. In very simple terms, this branch of biology works to rewrite an organism's … |
